Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine

Vaccines are the most effective strategy to mitigate the global impact of COVID-19. However, vaccine hesitancy is common, particularly among minorities. Guillain-Barré syndrome (GBS) is the most common autoimmune illness of the peripheral nervous system, occurring at an incidence of 1.1/100,000 worl...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Grimshaw, Miguel, Michel-Chávez, Anaclara, Vera-Zertuche, Juan Mauricio, Galnares-Olalde, Javier Andrés, Hernández-Vanegas, Laura E., Figueroa-Cucurachi, Melissa, Paredes-Ceballos, Orlando, Reyes-Terán, Gustavo, Carbajal-Sandoval, Guillermo, Ceballos-Liceaga, Santa Elizabeth, Arauz, Antonio, Valdés-Ferrer, Sergio Iván
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332675/
https://www.ncbi.nlm.nih.gov/pubmed/34358692
http://dx.doi.org/10.1016/j.clim.2021.108818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332675/
https://www.ncbi.nlm.nih.gov/pubmed/34358692
http://dx.doi.org/10.1016/j.clim.2021.108818

Ejemplares similares